1. Varicella Infection in an Immunized Pediatric Living Donor Liver-Transplant Recipient
- Author
-
Reshu Agarwal, Vibha Mehta, Viniyendra Pamecha, Krithiga Ramachandran, Ekta Gupta, and Seema Alam
- Subjects
Pediatrics ,medicine.medical_specialty ,Varicella vaccine ,viruses ,varicella-zoster virus infection ,Population ,Disseminated infection ,Case Report ,Infectious and parasitic diseases ,RC109-216 ,medicine.disease_cause ,Herpesviridae ,medicine ,Transmission risks and rates ,DNA polymerase chain reaction ,Chicken Pox ,education ,living donor liver transplantation ,education.field_of_study ,varicella-zoster virus ,Chickenpox ,business.industry ,Varicella zoster virus ,virus diseases ,vaccine efficacy ,medicine.disease ,Vaccine efficacy ,Infectious Diseases ,business - Abstract
Varicella-zoster virus (VZV) is a DNA virus belonging to the Herpesviridae family. Primary infection causes chickenpox followed by latency in the sensory ganglia, which can sometimes reactivate leading to herpes zoster. Chicken pox is generally a mild disease of childhood with a secondary attack rate of >85%, but disseminated VZV infection with visceral involvement and fatal outcome may occur in immunocompromised individuals. Indian Academy of Pediatrics recommends two doses of live-attenuated varicella vaccine in healthy unexposed children at 15-18 months and then at 4-6 years of age. The effectiveness of a single dose of vaccine is around 85% and with a two-dose schedule is as high as 92%. Despite the vaccine-induced protection, community-acquired VZV infections still remain a problem in immunocompromised population. We hereby report a case of a previously immunized pediatric liver-transplant recipient who acquired VZV infection. This case report clearly highlights the importance of strict environmental infection control practices, early suspicion, diagnosis, and management in such cases.
- Published
- 2021